Nephros Inc (NEPH)

NASD · Healthcare · Medical Instruments & Supplies · USA

Nephros Inc is a micro cap company (market value under $300 million) in the Medical Instruments & Supplies industry.

Nephros develops and markets medical-grade water filtration solutions for points of use, including products for infection control and dialysis water purification. The company also offers commercial filters that improve taste and odor, reduce contaminants including Total PFAS, and remove lead and particulates. Its FDA-cleared products serve hospitals, dialysis clinics, foodservice operations, laboratories, manufacturing facilities, and other industries requiring water purity.

From its FY2025 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the Nephros Inc stock.

Our verdict on NEPH

Slightly undervalued: intrinsic value $3.34 per share, market price $2.90, margin of safety 13.0% (as of 2026-11-17).

Discounting its cash flows at 12.5% (average of 3 methods) values the shares at $3.34; the price of $2.90 is 13% below that value, and 66% of that value comes from beyond year five.

ETFs with the most weight in NEPH

3 more funds hold it; the full list is part of the paid plan.

More on NEPH

Browse

Peers in Medical Instruments & Supplies

All 52 Medical Instruments & Supplies stocks

Cheaper than NEPH in Medical Instruments & Supplies

Is NEPH undervalued or overvalued?

NEPH is slightly undervalued (as of the 2026-11-17 close). Discounting its cash flows at 12.5% (average of 3 methods) values the shares at $3.34; the price of $2.90 is 13% below that value, and 66% of that value comes from beyond year five.

What is the intrinsic value of NEPH?

$3.34 per share (as of the 2026-11-17 close), against a market price of $2.90. That is a margin of safety of 13.0%. The value is the average of the 3 valuation methods that apply to this company, recomputed every night after the US close.